Blood

The study analyzes exons 2, 3, 5, 6, and 11 of a gene associated with an inherited vascular and cerebrovascular disease called CADASIL syndrome, as a second step in diagnosing the disease.

The study analyzes exonsó7-10 of the NOTCH3 gene as the third step in the diagnosis of a hereditary vascularófatal disease called CADASIL syndrome

The study is identifying the form of the APOE gene responsible for the genetic predisposition to Alzheimer's disease and atherosclerotic diseases

The test allows determination of the concentration of the drug everolimus in the blood, which is used in monitoring anti-cancer therapy.

The test detects a gene mutation thatóra causes factor XIII clotting deficiency, a rare inherited blood clotting disorder in which factor XIII, a protein in the blood responsible for stabilizing the clot, malfunctions or is present in insufficient amounts.

The test, which detects point mutations in the DMD gene, or certain changes in the genetic material (DNA), aims to diagnose Duchenne muscular dystrophy, an inherited disease associated with muscle weakness.

The genetic screening test detects a version of one of the genesów (called the B*57:01 allele) thatóra associated with hypersensitivity to the drug abacavir, in order to select a treatment strategy.

Molecular karyotype by aCGH is an advanced genetic test thatóry identifies uncompensated chromosomal abnormalities associated with birth defects. It utilizes a porónary genomic hybridization with microarray (aCGH) method for accurate karyotype analysis.

The genetic test involves the analysis of 67 cancer-related genes and assesses the risk of rós different typesóof cancer in a single test.

The blood test is based on the measurement of malondialdehyde levels, an indicator of oxidative stress thatós increased in cardiovascular, nervous system, metabolic and cancer diseases.